Welcome to LookChem.com Sign In|Join Free

CAS

  • or

131123-76-7

Post Buying Request

131123-76-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

131123-76-7 Usage

Uses

5,7-Dichlorokynurenic acid is a potent NMDA receptor glycine binding site antagonist.

Biological Activity

Potent antagonist at the glycine site of the NMDA receptor (K i = 79 nM vs. [ 3 H]-glycine).

Check Digit Verification of cas no

The CAS Registry Mumber 131123-76-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,1,1,2 and 3 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 131123-76:
(8*1)+(7*3)+(6*1)+(5*1)+(4*2)+(3*3)+(2*7)+(1*6)=77
77 % 10 = 7
So 131123-76-7 is a valid CAS Registry Number.
InChI:InChI=1/C10H5Cl2NO3/c11-4-1-5(12)9-6(2-4)13-7(10(15)16)3-8(9)14/h1-3H,(H,13,14)(H,15,16)

131123-76-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name 5,7-DICHLOROKYNURENIC ACID SODIUM SALT

1.2 Other means of identification

Product number -
Other names 5,7-DICHLORO-4-HYDROXYQUINOLINE-2-CARBOXYLIC ACID

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:131123-76-7 SDS

131123-76-7Relevant articles and documents

2-AMINOCARBONYL-QUINOLINE COMPOUNDS AS PLATELET ADENOSINE DIPHOSPHATE RECEPTOR ANTAGONISTS

-

Page 44, (2010/02/07)

Compounds of formula (I), where m, n, R1, R2, R3, R4 and R6 are described herein, are useful as inhibitors of platelet adenosine diphosphate. Pharmaceutical compositions containing these compounds, methods of using these compounds as antithrombotic agents and processes for synthesizing these compounds are also described herein.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 131123-76-7